The Gamma Gap and All-Cause Mortality.
The difference between total serum protein and albumin, i.e. the gamma gap, is a frequently used clinical screening measure for both latent infection and malignancy. However, there are no studies defining a positive gamma gap. Further, whether it is an independent risk factor of mortality is unknown...
Main Authors: | Stephen P Juraschek, Alison R Moliterno, William Checkley, Edgar R Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4668045?pdf=render |
Similar Items
-
Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy.
by: Gigi Y Liu, et al.
Published: (2020-01-01) -
NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
by: Justin B. Echouffo‐Tcheugui, et al.
Published: (2023-06-01) -
Number of teeth is associated with all-cause and disease-specific mortality
by: Yau-Hua Yu, et al.
Published: (2021-11-01) -
Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study
by: Eun Ju Cho, et al.
Published: (2023-01-01) -
All-cause and cause-specific mortality in patients with depression in Scotland
by: R. Alotaibi, et al.
Published: (2023-03-01)